- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 6.32M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 80 sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $52K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $6.66M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $0 |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $575.08M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.17M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.62M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $2K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $156.23M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $104.52M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $0 |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $0 |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $639.82M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $460.47M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $802.63M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $571.52M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.78 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.78 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.09M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $0 |
| Net Income | Q1 2026 · Mar 31, 2026 | $4.91M |
| Net Income | Q1 2026 · Mar 31, 2025 | $0 |
| Revenue | Q1 2026 · Mar 31, 2026 | $16.48M |
| Revenue | Q1 2026 · Mar 31, 2025 | $0 |